Jazz Pharmaceuticals (JAZZ) EBIT Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 38.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.73% |
| Dec 31, 2025 | 43.68% |
| Sep 30, 2025 | 32.43% |
| Jun 30, 2025 | -115.61% |
| Mar 31, 2025 | -38.18% |
| Dec 31, 2024 | 56.91% |
| Sep 30, 2024 | 109.33% |
| Jun 30, 2024 | 69.46% |
| Mar 31, 2024 | -25.81% |
| Dec 31, 2023 | -10.94% |
| Sep 30, 2023 | -4.22% |
| Jun 30, 2023 | -7.34% |
| Mar 31, 2023 | 38.64% |
| Dec 31, 2022 | -84.70% |
| Sep 30, 2022 | -42.91% |
| Jun 30, 2022 | -25.18% |
| Mar 31, 2022 | -13.17% |
| Dec 31, 2021 | -35.62% |
| Sep 30, 2021 | -46.83% |
| Jun 30, 2021 | -34.89% |
| Mar 31, 2021 | 22.68% |
| Dec 31, 2020 | 7.09% |
| Sep 30, 2020 | 31.41% |
| Jun 30, 2020 | 6.28% |
| Mar 31, 2020 | -50.27% |
| Dec 31, 2019 | -28.21% |
| Sep 30, 2019 | -0.78% |
| Jun 30, 2019 | 6.58% |
| Mar 31, 2019 | 3.35% |
| Dec 31, 2018 | 20.17% |
| Sep 30, 2018 | 12.80% |
| Jun 30, 2018 | -0.02% |
| Mar 31, 2018 | -9.06% |
| Dec 31, 2017 | 2.82% |
| Sep 30, 2017 | 14.21% |
| Jun 30, 2017 | 30.48% |
| Mar 31, 2017 | 59.30% |
| Sep 30, 2016 | 10.66% |
| Jun 30, 2016 | 29.85% |
| Mar 31, 2016 | 21.12% |
| Dec 31, 2015 | 16.53% |
| Sep 30, 2015 | 33.49% |
| Jun 30, 2015 | 57.25% |
| Mar 31, 2015 | 48.38% |
| Dec 31, 2014 | 51.09% |
| Sep 30, 2014 | 19.86% |
| Jun 30, 2014 | 29.94% |
| Mar 31, 2014 | -70.41% |
| Sep 30, 2013 | 90.95% |
| Jun 30, 2013 | 93.83% |